Is BN a Good Stock to Buy? The Bull and Bear Case (2026)

Last updated November 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Brookfield Corporation (BN) rests on Fee-bearing capital and carried interest at BAM: BAM's fee-bearing capital of ~$672 billion at the end of the second quarter of 2026 grew ~19% year over year and fee-related earnings rose ~20%, driven by a record ~$77 billion of quarterly inflows; the seventh private equity flagship ($7 billion) and sixth infrastructure flagship ($9 billion) are each on track to be the largest in their series. The bear case rests on the reported financials are hard to underwrite: consolidation pulls in revenue and debt from entities BN does not fully own, so ~$81 billion of trailing revenue and ~$1.4 billion of attributable net income describe the same company, and an investor has to accept management's distributable earnings framing to value it. Analysts covering it publish targets from $31.00 to $61.00 against a $41.83 price, so even the professionals disagree by 56% of their own average. We do not give a verdict. Each case is set out below at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

Brookfield Corporation sits at the top of the Brookfield group and reports through three pillars. Asset management runs through its roughly 73% interest in Brookfield Asset Management, whose fee-bearing capital reached a record ~$672 billion at the end of June 2026, up ~19% year over year, after record quarterly fundraising of ~$77 billion; Brookfield completed its acquisition of the rest of credit manager Oaktree in July 2026. Wealth solutions is the annuity, pension-risk-transfer and P&C insurance business (Brookfield Wealth Solutions, built from American National, Argo Group, American Equity Life and, since the 2026 acquisition, UK annuity provider Just Group) that gathers policyholder money and invests it alongside Brookfield's own funds; insurance assets reached ~$191 billion at mid-year, including ~$45 billion added by Just Group. The third pillar is the operating businesses, held partly through the listed affiliates: Brookfield Renewable (BEP/BEPC), Brookfield Infrastructure (BIP/BIPC), Brookfield Business Partners (BBU/BBUC) and a wholly owned real estate book that includes Canary Wharf, Brookfield Place and Ala Moana Center. Bruce Flatt has run the company since 2002, and the December 2022 reorganisation is what created the BN-versus-BAM split: BN kept the balance sheet and the carried interest, BAM was carved out as the pure-play, high-payout manager. The investment picture is a valuation puzzle as much as a business question. Shares closed at ~$36.84 on October 16, 2026, down ~21% year to date, ~13% over three months and ~16% over one year, for a market capitalisation of ~$82 billion against revenue of ~$81 billion over the trailing twelve months. Net income attributable to shareholders over the last twelve months was only ~$1.4 billion, which puts the reported P/E in the high 60s on Yahoo's figures. That gap exists because consolidation drags in revenue and assets Brookfield does not own outright, and because depreciation on long-lived infrastructure suppresses accounting profit. Management therefore steers investors to distributable earnings: ~$1.5 billion or ~$0.66 per share in the second quarter of 2026 and ~$6.2 billion (~$2.61 per share) over twelve months, with distributable earnings before realizations up ~15% per share to ~$0.61. The dividend is deliberately small, ~$0.28 per share annualised for a yield near ~0.8%, because capital is retained for buybacks and new commitments; Brookfield bought back ~$580 million of shares in the first half at an average of ~$42. A structural simplification approved by shareholders on July 16, 2026 will fold Brookfield Wealth Solutions into a new parent that keeps the BN ticker on both exchanges. Third quarter 2026 results are scheduled for November 12, 2026.

The bull case: what would have to be true for $61.00

The most optimistic published target on BN is $61.00, +45.8% from the $41.83 price as of November 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. Fee-bearing capital and carried interest at BAM

BAM's fee-bearing capital of ~$672 billion at the end of the second quarter of 2026 grew ~19% year over year and fee-related earnings rose ~20%, driven by a record ~$77 billion of quarterly inflows; the seventh private equity flagship ($7 billion) and sixth infrastructure flagship ($9 billion) are each on track to be the largest in their series. BN captures ~73% of that fee stream plus essentially all of the accumulated carried interest from the older fund vintages, which stood at ~$12.5 billion unrealized at mid-year. Fee revenue is the contracted, visible half of the story; carried interest is the lumpy half that only shows up when funds exit assets. Realizations were ~$121 million in the second quarter, a reminder that exit timing, not fund performance, sets the quarterly cadence.

2. The insurance and annuity flywheel

Brookfield Wealth Solutions writes annuities and pension risk transfer, then invests the float into credit and infrastructure originated by Brookfield's own platforms, earning the spread twice. Its distributable earnings rose ~23% in the second quarter of 2026 to ~$480 million, helped by the first full quarter of Just Group, with a net investment income yield of ~5.7% and a gross spread of ~2.2% in North America. Folding the business into BN, approved by shareholders in July 2026, gives the insurance balance sheet direct access to the parent's capital, which is the stated reason for the merger.

3. Power and data centre buildout

Brookfield's renewables and infrastructure platforms own the two inputs AI capacity needs most: generation and land with grid connections. The Microsoft renewable framework agreement covering ~10.5 GW of delivery, the data centre platforms Compass Datacenters, Data4 and Ascenty, a partnership with Bloom Energy expanded to $25 billion for behind-the-meter fuel cells at data centres, and a $17.5 billion US Department of Energy financing commitment for long-lead equipment for Westinghouse reactors are the concrete expressions of it. This is also where the largest cheques go, so it drives both fundraising and the size of the balance sheet.

4. Capital recycling and buybacks

Brookfield executed ~$40 billion of asset sales in the first half of 2026, including One Churchill Place at Canary Wharf for £750 million and the Multiplex construction business for $650 million, and ended June with a record ~$210 billion of deployable capital. Growth in per-share value comes largely from selling mature assets at a premium and shrinking the share count rather than from adding gross assets: the company repurchased ~$580 million of stock in the first half at an average of ~$42, above the October 2026 price. Corporate debt carries a 15-year weighted-average term with no 2026 maturities, and in October it raised C$150 million of preferred shares. The retained dividend near ~0.8% is what funds the buybacks.

The bear case: what would have to be true for $31.00

The most pessimistic published target is $31.00, -25.9% from the current price. It is neither a floor nor a forecast; it is roughly what one analyst thinks Brookfield Corporation is worth if the risks below bite instead of the drivers above.

The reported financials are hard to underwrite: consolidation pulls in revenue and debt from entities BN does not fully own, so ~$81 billion of trailing revenue and ~$1.4 billion of attributable net income describe the same company, and an investor has to accept management's distributable earnings framing to value it. Leverage sits mostly at the asset level in non-recourse form (Yahoo shows ~$269 billion of consolidated debt), which limits contagion but leaves refinancing exposed to long rates and credit spreads across hundreds of separate structures. The office and retail real estate book has already required writedowns and remains the least liquid piece, though leasing improved in 2026. The insurance pillar, now larger after Just Group, introduces a different risk set entirely: spread compression if rates fall, reserve assumptions on long-dated annuities, and regulators in multiple jurisdictions reviewing private-capital ownership of annuity liabilities. Integrating Oaktree adds execution risk in credit. Carried interest and realization gains depend on exit markets that shut for long stretches, and BN's ~1.8 beta means the stock has historically fallen harder than the index when sentiment turns, as the ~21% decline in 2026 shows.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding BN already, these risks exist either way; what to check is whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on BN

10 analysts cover BN, with an average target of $53.75 (+28.5% against $41.83) and a split of 10 buy, 0 hold, 1 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the BN forecast and price target page.

How is BN valued? (as of October 2026)

Price
$41.83
Market cap
$93.38B
P/E (TTM)
77.46
Forward P/E
7.13
Price / book
2.20
Beta
1.83
52-week range
$35.61 to $49.57

Snapshot for BN as of November 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

  • Share price / market cap: ~$36.84 per share, ~$82 billion (Oct 16, 2026 close)
  • Revenue (TTM): ~$81 billion
  • Net income attributable (TTM): ~$1.4 billion, a reported P/E in the high 60s
  • Distributable earnings (Q2 2026): ~$1.5 billion, ~$0.66 per share (~$0.61 before realizations, up ~15%)
  • Distributable earnings (TTM): ~$6.2 billion, ~$2.61 per share
  • Fee-bearing capital at BAM: ~$672 billion, up ~19% year over year
  • Dividend: ~$0.28 per share annualised, ~0.8% yield

At ~$36.84 the shares trade at roughly 14 times trailing distributable earnings of ~$2.61 per share, cheaper than earlier in 2026 after a ~21% slide, while the reported P/E in the high 60s is not a like-for-like multiple: depreciation on infrastructure and the share of consolidated profit belonging to outside partners both sit between revenue and attributable earnings. Brookfield's own buybacks earlier in the year averaged ~$42, above the current price. Third quarter 2026 results are scheduled for November 12, 2026.

How do you decide if BN is a buy?

Whether BN is a buy is easier to judge through four narrower questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold BN indirectly through an index or sector ETF before adding more.

What would change your mind on BN

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: Fee-bearing capital and carried interest at BAM stalls in the reported numbers. A shift in the narrative around them is not enough on its own.
  • Bear case breaks if: the reported financials are hard to underwrite: consolidation pulls in revenue and debt from entities BN does not fully own, so ~$81 billion of trailing revenue and ~$1.4 billion of attributable net income describe the same company, and an investor has to accept management's distributable earnings framing to value it fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the BN stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about BN against your real portfolio and see your actual exposure before deciding.

Investing in Brookfield Corporation with AI

Connect the broker you already use and ask Walnut's AI how BN fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

Is BN a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on Fee-bearing capital and carried interest at BAM, with revenue (ttm) at ~$81 billion. The bear case rests on the reported financials are hard to underwrite: consolidation pulls in revenue and debt from entities BN does not fully own, so ~$81 billion of trailing revenue and ~$1.4 billion of attributable net income describe the same company, and an investor has to accept management's distributable earnings framing to value it. Analysts covering it are spread from $31.00 to $61.00, a spread wide enough to show the question is contested. If you believe the thesis, the questions that matter next are sizing and overlap; timing comes after. Walnut is not an investment adviser and this is not a recommendation.

Should I sell BN?

+

Nobody can answer that for you, and a more useful version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The reported financials are hard to underwrite: consolidation pulls in revenue and debt from entities BN does not fully own, so ~$81 billion of trailing revenue and ~$1.4 billion of attributable net income describe the same company, and an investor has to accept management's distributable earnings framing to value it. If that risk is what you were worried about and it is now playing out, take it seriously. If the price simply fell while the thesis held, the situation is different. The most pessimistic published target is $31.00, -25.9% from the $41.83 price, which is one analyst's downside case. It is not a floor. Walnut is not an investment adviser.

What is the bull case for BN?

+

Fee-bearing capital and carried interest at BAM. BAM's fee-bearing capital of ~$672 billion at the end of the second quarter of 2026 grew ~19% year over year and fee-related earnings rose ~20%, driven by a record ~$77 billion of quarterly inflows; the seventh private equity flagship ($7 billion) and sixth infrastructure flagship ($9 billion) are each on track to be the largest in their series. The most optimistic analyst target on BN is $61.00, +45.8% from the $41.83 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for BN?

+

The reported financials are hard to underwrite: consolidation pulls in revenue and debt from entities BN does not fully own, so ~$81 billion of trailing revenue and ~$1.4 billion of attributable net income describe the same company, and an investor has to accept management's distributable earnings framing to value it. Leverage sits mostly at the asset level in non-recourse form (Yahoo shows ~$269 billion of consolidated debt), which limits contagion but leaves refinancing exposed to long rates and credit spreads across hundreds of separate structures. The office and retail real estate book has already required writedowns and remains the least liquid piece, though leasing improved in 2026. The insurance pillar, now larger after Just Group, introduces a different risk set entirely: spread compression if rates fall, reserve assumptions on long-dated annuities, and regulators in multiple jurisdictions reviewing private-capital ownership of annuity liabilities. Integrating Oaktree adds execution risk in credit. Carried interest and realization gains depend on exit markets that shut for long stretches, and BN's ~1.8 beta means the stock has historically fallen harder than the index when sentiment turns, as the ~21% decline in 2026 shows. The most pessimistic published target is $31.00, -25.9% from the current price, which is roughly what one analyst thinks the stock is worth if these risks bite and the drivers do not.

What does Brookfield Corporation do?

+

Parent holding company of the Brookfield group, owning most of Brookfield Asset Management plus wealth solutions and direct stakes in the listed affiliates.

What would have to change for BN to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Fee-bearing capital and carried interest at BAM) stalling in the reported numbers (a change in the narrative alone does not count), the risk above (the reported financials are hard to underwrite: consolidation pulls in revenue and debt from entities BN does not fully own, so ~$81 billion of trailing revenue and ~$1.4 billion of attributable net income describe the same company, and an investor has to accept management's distributable earnings framing to value it) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What company is the ticker BN?

+

BN is Brookfield Corporation, a Canadian holding company headquartered in Toronto and listed on both the NYSE and the Toronto Stock Exchange. It is the parent of the Brookfield group, with ~$672 billion of fee-bearing capital managed through BAM and ~$191 billion of insurance assets as of June 30, 2026.

How is BN different from BAM?

+

BAM (Brookfield Asset Management) is the pure-play asset manager that was carved out in December 2022 and pays out nearly all of its fee-related earnings, yielding several times BN's ~0.8%. BN owns roughly 73% of BAM plus the insurance arm, the carried interest and the direct equity stakes, and retains its cash for reinvestment and buybacks instead.

What are the other Brookfield tickers?

+

Brookfield Renewable trades as BEP and BEPC, Brookfield Infrastructure as BIP and BIPC, Brookfield Business Partners as BBU and BBUC, and Brookfield Wealth Solutions as BNT. The C-share versions are corporations rather than partnerships, which changes the tax reporting. BN sits above all of them and consolidates most of them into its statements.

Walnut is informational, not investment advice, and gives no verdict on BN. Analyst targets referenced here come from a November 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.

The case for and against similar stocks